BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6365361)

  • 1. Further studies on the hypernoradrenergic state of treated hypertensives: effect of captopril.
    Mitchell HC; Pettinger WA; Gianotti L; Reed G; Kirk L; Kuhnert L; Matthews C; Anderson R
    Clin Exp Hypertens A; 1983; 5(10):1611-27. PubMed ID: 6365361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypernoradrenergic state in vasodilator drug-treated hypertensive patients: effect of clonidine.
    Mitchell HC; Pettinger WA
    J Cardiovasc Pharmacol; 1980; 2(1):1-7. PubMed ID: 6154200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
    Mitchell HC; Pettinger WA
    Clin Pharmacol Ther; 1981 Sep; 30(3):297-302. PubMed ID: 6115731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
    Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade.
    Brunner HR; Gavras H; Waeber B
    Clin Exp Hypertens (1978); 1980; 2(3-4):639-57. PubMed ID: 6253243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.
    Kusaka M; Atarashi K; Matsumoto K; Sumida Y; Matsuura H; Shingu T; Kajiyama G
    Am J Hypertens; 1991 Sep; 4(9):735-9. PubMed ID: 1930858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response of clonidine on plasma catecholamines in the hypernoradrenergic state associated with vasodilator beta-blocker therapy.
    Mitchell HC; Pettinger WA
    J Cardiovasc Pharmacol; 1981; 3(3):647-54. PubMed ID: 6168844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
    Weinberger MH
    Am J Cardiol; 1982 Apr; 49(6):1542-3. PubMed ID: 7041594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
    Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril withdrawal after chronic therapy.
    Vlasses PH; Koffer H; Ferguson RK; Green PJ; McElwain GE
    Clin Exp Hypertens (1978); 1981; 3(5):929-37. PubMed ID: 7026198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of sublingual captopril on plasma catecholamine levels during hypertensive emergencies and cold immersion.
    Polonia JJ; Monteiro A; Esteves A; Cunha ME; Santos ML; Coutinho J; Coelho JL; Brandao FA; Cerqueira-Gomes M
    Am J Med; 1988 Mar; 84(3A):148-51. PubMed ID: 3064593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function in long-term minoxidil-treated patients.
    Mitchell HC; Pettinger WA
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S163-72. PubMed ID: 6156352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients.
    Clementi WA; Durst NL; McNay JL; Keeton TK
    Hypertension; 1986 Mar; 8(3):229-37. PubMed ID: 3512428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of captopril on blood pressure in essential hypertensive patients with low or normal plasma renin activity. Interference with autonomic nervous system.
    Degli Esposti E; Chiarini C; Masi A; Santoro A; Sturani A; Umile A; ZuccalĂ  A; Zucchelli P
    Clin Exp Hypertens (1978); 1981; 3(3):439-54. PubMed ID: 7018859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension].
    Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
    Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of captopril on vascular noradrenergic transmission during the development of two-kidney, one clip Goldblatt hypertension in rats.
    Eikenburg DC; Lokhandwala MF
    J Hypertens; 1983 Aug; 1(2):115-22. PubMed ID: 6099381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.